Predictions
Viking Therapeutics Inc
Start price
Target price
Perf. (%)
€69.50
29.04.24
29.04.24
€100.00
31.03.26
31.03.26
-0.75%
03.05.24
03.05.24
Could be very worthwhile Investment >20% year
Cardiff Oncology Inc.
Start price
Target price
Perf. (%)
€3.73
25.04.24
25.04.24
-
25.04.25
25.04.25
0.80%
27.04.24
27.04.24
Risky Investment
Fate Therapeutics Inc.
Start price
Target price
Perf. (%)
€3.60
25.04.24
25.04.24
-
25.04.25
25.04.25
-2.00%
27.04.24
27.04.24
Could be worthwhile Investment >10% per year
Mersana Therapeutics
Start price
Target price
Perf. (%)
€2.68
24.04.24
24.04.24
-
24.04.25
24.04.25
4.63%
26.04.24
26.04.24
Could be worthwhile Investment >10% per year
Plug Power Inc.
Start price
Target price
Perf. (%)
€2.49
23.04.24
23.04.24
€3.00
23.04.25
23.04.25
-8.41%
27.04.24
27.04.24
Good rating
Growths much faster than the competition
Leading role in innovation
Very good company culture
Fibrogen Inc.
Start price
Target price
Perf. (%)
€1.07
19.04.24
19.04.24
-
19.04.25
19.04.25
-10.90%
28.04.24
28.04.24
Could be very worthwhile Investment >20% year
Albemarle Corp
Start price
Target price
Perf. (%)
€108.34
17.04.24
17.04.24
-
17.04.25
17.04.25
6.44%
02.05.24
02.05.24
Growths faster than the competition
aTyr Pharma Inc
Start price
Target price
Perf. (%)
€1.66
14.04.24
14.04.24
-
14.04.25
14.04.25
-13.86%
28.04.24
28.04.24
Could be worthwhile Investment >10% per year
Inotiv Inc.
Start price
Target price
Perf. (%)
€5.50
13.04.24
13.04.24
€4.00
13.04.25
13.04.25
-32.36%
27.04.24
27.04.24
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Little Investments for future growth
Cassava Sciences Inc.
Start price
Target price
Perf. (%)
€22.07
13.04.24
13.04.24
€2.00
13.04.25
13.04.25
-5.44%
27.04.24
27.04.24
Probably not worthwhile Investment
EBIT decline/stagnation expected
negative Cash Flow expected
Bad rating
Nektar Therapeutics
Start price
Target price
Perf. (%)
€1.50
11.04.24
11.04.24
-
11.04.25
11.04.25
3.27%
14.04.24
14.04.24
Risky Investment
Plug Power Inc.
Start price
Target price
Perf. (%)
€2.91
08.04.24
08.04.24
€3.00
08.04.25
08.04.25
-21.66%
27.04.24
27.04.24
Good rating
Revenue growth >5% per year expected
Higher EBIT margin than peer group
Fair valuation
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€66.50
07.04.24
07.04.24
-
07.04.25
07.04.25
0.75%
14.04.24
14.04.24
Could be very worthwhile Investment >20% year
Advanced Micro Devices Inc.
Start price
Target price
Perf. (%)
€163.46
04.04.24
04.04.24
€165.00
04.04.25
04.04.25
-9.04%
27.04.24
27.04.24
Could be worthwhile Investment >10% per year
Top 10 in its market
Small cyclical dependencies
Future proof or reliable business model
Advanced Micro Devices Inc.
Start price
Target price
Perf. (%)
€163.46
04.04.24
04.04.24
€165.00
04.04.25
04.04.25
-9.04%
27.04.24
27.04.24
Could be worthwhile Investment >10% per year
Top 10 in its market
Small cyclical dependencies
Future proof or reliable business model
Advanced Micro Devices Inc.
Start price
Target price
Perf. (%)
€163.46
04.04.24
04.04.24
€165.00
04.04.25
04.04.25
-9.04%
27.04.24
27.04.24
Could be worthwhile Investment >10% per year
Top 10 in its market
Small cyclical dependencies
Future proof or reliable business model
Occidental Petroleum Corp.
Start price
Target price
Perf. (%)
€61.99
02.04.24
02.04.24
€55.00
02.04.25
02.04.25
5.50%
13.04.24
13.04.24
Probably not worthwhile Investment
Low dividend yield expected
Lower EBIT Margin than peer group
Revenue decline/stagnation expected